Item 2.02. Results of Operations and Financial Condition.
On January 11, 2022, Bioventus Inc. (the Company) issued a press release
announcing its preliminary revenue for the fourth quarter and full year ended
December 31, 2021. A copy of the press release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K.
These estimated preliminary results for the fourth quarter and full year ended
December 31, 2021 are derived from the preliminary internal financial records of
the Company and are subject to revisions based on our procedures and controls
associated with the completion of our financial reporting, including the audit
of our financial statements and all customary reviews and approvals. These
estimated preliminary results should not be viewed as a substitute for financial
statements prepared in accordance with U.S. GAAP. Our independent registered
public accounting firm has not audited and does not express an opinion or any
other form of assurance with respect to these estimated preliminary results. It
is possible that we or our independent registered public accounting firm may
identify items that would require us to make adjustments to the preliminary
estimates set forth in Exhibit 99.1 as we complete our financial statements and
that our actual results may differ materially from these preliminary estimates.
Accordingly, undue reliance should not be placed on these preliminary estimates.
The information contained in this Item 2.02, including Exhibit 99.1 hereto,
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing made by the Company under the Securities Act of 1933, as amended (the
Securities Act), or the Exchange Act, regardless of any general incorporation
language in such filings, unless expressly incorporated by specific reference in
such filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and
not filed:
  Exhibit No.             Description

99.1                        Preliminary Revenue Fourth Quarter and Full Year 2021

104                       Cover Page Interactive Data File (embedded within

the Inline XBRL document)

© Edgar Online, source Glimpses